Park WK - Search Results

1

Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP opening.

Elkamhawy A, Park JE, Hassan AHE, Pae AN, Lee J, Park BG, Paik S, Do J, Park JH, Park KD, Moon B, Park WK, Cho H, Jeong DY, Roh EJ. Elkamhawy A, et al. Among authors: park jh, park je, park kd, park bg, park wk. Eur J Pharm Sci. 2017 Jun 15;104:366-381. doi: 10.1016/j.ejps.2017.04.015. Epub 2017 Apr 21. Eur J Pharm Sci. 2017. PMID: 28435076

2

A histomorphometric study of corneal endothelial cells in normal human fetuses.

Ko MK, Park WK, Lee JH, Chi JG. Ko MK, et al. Among authors: park wk. Exp Eye Res. 2001 Apr;72(4):403-9. doi: 10.1006/exer.2000.0964. Exp Eye Res. 2001. PMID: 11273668

3

Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.

Park WK, Jeong D, Yun CW, Lee S, Cho H, Kim GD, Koh HY, Pae AN, Cho YS, Choi KI, Jung JY, Jung SH, Kong JY. Park WK, et al. Pharmacol Res. 2003 Dec;48(6):615-22. doi: 10.1016/s1043-6618(03)00242-1. Pharmacol Res. 2003. PMID: 14527827

4

Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives.

Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, Lee S, Kim BK. Cho H, et al. Among authors: park y, park wk. Pharmacol Res. 2004 Jan;49(1):37-43. doi: 10.1016/s1043-6618(03)00248-2. Pharmacol Res. 2004. PMID: 14597150

5

KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.

Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY. Park WK, et al. Pharmacol Biochem Behav. 2005 Oct;82(2):361-72. doi: 10.1016/j.pbb.2005.09.006. Epub 2005 Oct 10. Pharmacol Biochem Behav. 2005. PMID: 16216322

6

Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.

Lee KI, Park Y, Park SJ, Hwang JH, Lee SJ, Kim GD, Park WK, Lee S, Jeong D, Kong JY, Kang HK, Cho H. Lee KI, et al. Among authors: park y, park sj, park wk. Bioorg Med Chem Lett. 2006 Feb;16(3):737-42. doi: 10.1016/j.bmcl.2005.08.115. Bioorg Med Chem Lett. 2006. PMID: 16321529

7

New serotonin 5-HT(6) ligands from common feature pharmacophore hypotheses.

Kim HJ, Doddareddy MR, Choo H, Cho YS, No KT, Park WK, Pae AN. Kim HJ, et al. Among authors: park wk. J Chem Inf Model. 2008 Jan;48(1):197-206. doi: 10.1021/ci700160t. Epub 2007 Nov 29. J Chem Inf Model. 2008. PMID: 18044950

8

Novel quinazolinone derivatives as 5-HT7 receptor ligands.

Na YH, Hong SH, Lee JH, Park WK, Baek DJ, Koh HY, Cho YS, Choo H, Pae AN. Na YH, et al. Among authors: park wk. Bioorg Med Chem. 2008 Mar 1;16(5):2570-8. doi: 10.1016/j.bmc.2007.11.049. Epub 2007 Nov 22. Bioorg Med Chem. 2008. PMID: 18083580

9

Preparation of piperazine derivatives as 5-HT7 receptor antagonists.

Yoon J, Yoo EA, Kim JY, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY. Yoon J, et al. Among authors: park choo hy, park wk. Bioorg Med Chem. 2008 May 15;16(10):5405-12. doi: 10.1016/j.bmc.2008.04.023. Epub 2008 Apr 15. Bioorg Med Chem. 2008. PMID: 18456500

10

Identification of novel serotonin 2C receptor ligands by sequential virtual screening.

Ahmed A, Choo H, Cho YS, Park WK, Pae AN. Ahmed A, et al. Among authors: park wk. Bioorg Med Chem. 2009 Jul 1;17(13):4559-68. doi: 10.1016/j.bmc.2009.05.003. Epub 2009 May 8. Bioorg Med Chem. 2009. PMID: 19464901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page